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Purpose  &  Methods:  The  aim  of  this  work  was  to study  the  clinicopathological  features
of  Kaposi  sarcoma  (KS)  & kaposiform  hemangioendothelioma  (KHE)  and  analyze  their
immunohistochemical  expression  of c-Kit,  CD34,  -SMA.  The  study  was  performed  on
cutaneous  10  classic  KS  &  8  KHE.
Results:  KHE  shows  several  dilated  lymphatic  channels,  focal  capillary  formation,  lack  of
nuclear atypia  and  mitosis  within  tumor  cells.  These  features  help  to exclude  Kaposi  sar-
coma in  spite  of  the kaposiform  pattern  of  tumor  cells. C-Kit  was expressed  by  tumor  cells
in  all  KHE  cases  and  in  60%  only  of KS. All elements  within  both  tumor  groups  expressed
CD34  antibody.  -SMA  was  expressed  by tumor  cells  in 70%  of KS cases  and  none  of  KHE.
Conclusion:  C-Kit  and  CD34  seem  to be reliable  at labeling  KS  and  KHE  as  they  can  help  in
diagnosis  of these  tumors  in  routinely  processed  tissue  but  they  don’t differentiate  between
them.  If -SMA  also  labeled  the  tumor,  then  KHE  diagnosis  can  be  ruled  out.  KS  &  KHE
exemplify  stem  cell  tumors  that  could  give  smooth  muscle  cell–like  phenotype  in KS. Anti
C-kit  therapy  should  be  tested  in  KS  & KHE  to  prevent  recurrence.
© 2016  Published  by  Elsevier  Ltd.  on  behalf  of  Saudi  Society  of  Microscopes.  This  is  an
open  access  article under  the  CC  BY-NC-ND  license. Introduction
Kaposi sarcoma (KS) has been ﬁrst described as an
diopathic hemorrhagic-pigmented sarcoma of the skin
“sarcoma idiopathicum multiplex hemorrhagicum”)
ffecting elderly male subjects by Moritz Kaposi in 1872
1]. Histogenesis of these tumors is still controversial in
pite of the authentic advancements that have been made
or their understanding. Some authors still consider them
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as a low-grade vascular tumor associated either with HIV
infection or immunosuppression [2,3].
Kaposiform hemangioendothelioma (KHE) is an inter-
mediate/borderline vascular neoplasm between a heman-
gioma and a malignant angiosarcoma that was initially
described by Zukerberg et al. [4]. It rarely metastasizes,
but is a locally aggressive neoplasm, does not have a ten-
dency for spontaneous regression and has characteristic
histopathological features. Tumor cell architectural pattern
resembles Kaposi sarcoma, along with lymphatic compo-
nent, namely lymphangioma/lymphangiomatosis [5].
C-Kit is a protein that plays an important role in
the development of hematopoietic stem cells, mast cells,
germ cells, melanocytes, and interstitial cells of Cajal. It is
roscopes. This is an open access article under the CC BY-NC-ND license
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encoded by the KIT gene located on chromosome 4q12 [6].
Through its interactions with its ligand; stem cell factor, c-
Kit mediates crucial cellular functions as cell proliferation,
intercellular adhesion and cellular spindling [7–9].
CD34 is a transmembrane phosphoglycoprotein, ﬁrst
identiﬁed in 1984 on hematopoietic stem and progeni-
tor cells [10]. It is expressed by a wide range of cells as
hematopoietic, stromal, epithelial, and endothelial cells.
CD34 has a role in inhibition or facilitation of adhe-
sion, cell proliferation, and regulation of differentiation
but its function as a surface antigen is not known yet
[11–14].
-Smooth muscle actin (-SMA) is a marker used for
differential diagnosis of several tumors. It stains smooth
muscle ﬁbers, ﬁbroblasts and myoﬁbroblasts and is overex-
pressed in some mesenchymal tumors such as leiomyoma,
leimyosarcoma, myoﬁbroblastoma, inﬂammatory myoﬁ-
broblastic tumor, and gastrointestinal stromal tumors with
myogenic differentiation [15–17].
The immunohistochemical features of tumors could
help in identiﬁcation of their histogenesis and in discov-
ering molecules that can be targeted as a new line in
treatment. The aim of this work was to study the clinico-
pathological features of Kaposi sarcoma (KS) & kaposiform
hemangioendothelioma (KHE) and analyze their immuno-
histochemical expression of c-Kit, CD34, -SMA.
2. Materials & Methods
This retrospective study was approved by the Ethical
Committee of our Faculty. It consisted of 10 clinically and
histologically proven cases of classic cutaneous Kaposi sar-
coma & 8 KHE. Patients were diagnosed and treated at our
University Hospital. All tissue samples were formalin-ﬁxed
and parafﬁn-embedded. Cases with history of immunosup-
pressive therapy, organ transplantation or HIV-1 infection
were excluded.
The immunohistochemical staining was performed on
parafﬁn-embedded tissues, using the UltraVision System
(LabVision, Fremont, CA, USA). The antibodies c-Kit (poly-
clonal rabbit) ready–to use (LabVision, Fremont, CA, USA),
CD34 (Qbend/10 clone), diluted at 1:100, and -SMA (1A4
clone), diluted at 1:50 (LabVision, Fremont, CA, USA) were
used. The heat-induced antigen retrieval was performed
in high-retrieval solution (LabVision) for c-KIT. In case
of CD34 and -SMA, pepsin-enzymatic retrieval (LabVi-
sion) was used. The slides were developed using DAB
(diaminobenzidine) solution. Counterstaining was  per-
formed using Mayer’s hematoxylin.
We assessed the cytoplasmic positivity of studied mark-
ers semiquantitatively in both tumor cells and vascular
endothelial cells and expressed it as percentage. In case
of positivity in more than 40% of tumor cells, we consid-
ered the cases with diffuse positivity. Cases that displayed
positivity in 10–40% of tumor cells were considered to
have focal positivity; the cut-off value of positivity was
10%. Besides, we assessed staining intensity for c-Kit and
scored it as 1+ (weak), 2+ (moderate) and 3+ (strong) [3,18].
Positive control slides were sections from human tonsils
for c-kit & CD34, and were sections from human intestined Ultrastructure 5 (2017) 49–57
for -SMA. Negative control slides consisted of sections to
which no primary antibody was added.
2.1. Statistical analysis
Statistical analysis was performed using SPSS for Win-
dows software (version 13.0; SPSS Inc. Chicago, IL, USA).
The t-2 test, Spearman rank correlation coefﬁcient, and one-
way  ANOVA were used for statistical analysis. P < 0.05 was
considered signiﬁcant.
3. Results
3.1. Clinicopaathological features
This study included 10 classic KS cases and 8 KHE
cases. The median age of classic KS cases of this study was
62.5±2.983 years (58-67 years) and that of KHE cases was
2.5±17.64 years (1-45 years). The study included 11 male
cases (8 had classic KS, 3 had KHE) and 7 female cases (2
had classic KS, 5 had KHE).
All KS cases and 4 KHE cases included in this study were
located in the lower limbs, while the remaining 4 KHE pre-
sented as neck mass in 2 cases and as chest wall mass in
the other 2 cases. All the tumors included in this study were
manifested as dark violaceous skin lesions ranging from 1
to 3 cm in diameter (median=2±0.66) that formed palpable
nodules in all KHE & in 7 cases of KS with top ulceration in
2 of them, and manifested as thick patch in the remaining
3 KS cases.
Microscopically, classic KS cases of the skin in this
study consisted of dermal proliferation of irregular slit-
like vascular channels with extravasated erythrocytes,
hemosiderin, and plasma cells. The endothelial cells were
plump or inconspicuous. In some areas, numerous small
capillaries were cut in cross-sections giving a sieve-like
appearance. Cellular atypia was  seen in eight cases. Mitotic
activity ranged from 3/50 HPF in 7 cases to 5/50 HPF in
the remaining 3 cases. The vascular channels inﬁltrated
between collagen bundles and surrounded existing blood
vessels and appendages. The studied cases were classiﬁed
into 2 types: Plaque stage (3 cases) that showed dermal pro-
liferation of spindle cells with slit-like spaces in-between
and nodular stage (7 cases) in which sarcomatous nodu-
lar proliferation of spindle cells totally replaced the dermis
and showed hyaline globules, extravasated erythrocytes,
and hemosiderin deposits (Fig. 1).
All KHE consisted of a well-circumscribed tumor with a
lobular architecture. The individual tumor nodules were
composed of subcutaneous and dermal proliferation of
a mixture of small capillaries and solid lobules of cells
arranged in a glomeruloid pattern. Proliferating cells are
round or ovoid, some contain hyaline globules and others
contain hemosiderin. Cytoplasmic vacuolization was a fre-
quent sign of all cases. Areas of hemorrhage and hemosidrin
deposits were seen but no cellular atypia or necrosis.
Mitotic activity ranged from 1-3/50 HPFs. Solid nodules in
four cases showed adjacent areas of lymphangiomatosis.
These vessels of the associated lymphangiomatosis were
lined by a discontinuous ﬂat endothelial cell layer (Fig. 2).
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rythrocytes, hemosiderin deposits and plasma cell inﬁltrate (b), inconsp
ellular atypia & hyaline globules (c) [H&E X40 (a) & X400 (b, c)].
.2. Immunohistochemical ﬁndings
.2.1. C-Kit expression:
This study showed that 4 (40%) classic KS cases (1 in
laque & 3 in nodular stages) were c-KIT negative. The
emaining 6 (60%) cases of classic KS showed focal pos-
tivity. Two (33.33%) of the later cases were in plaque
tage and 4 (66.67%) were in nodular stage. The c-Kit pos-
tivity was detected as granular cytoplasmic staining in
he spindle tumor cells, but no positivity was detected in
ndothelial cells of tumor vessels. Intensity of c-Kit posi-
ivity was strong (3 + ) in one case, moderate (2 + ) in 4 cases
nd weak (1 + ) in one case. Besides, focal c-Kit positivity of
ntrapped mast cells and basal keratinocytes that worked
s internal positive control was seen in all cases included
n this study (Fig. 3).
On the other hand, all (100%) KHE cases showed c-Kit
egativity in tumor vessels & associated lymphagimatosis
ining cells as well, and focal positivity in tumor cells. The
ntensity of c-Kit positivity was weak (1 + ) in all cases of
HE (Fig. 4)..2.2. CD34 expression:
Diffuse CD34 positivity was present as a positive inter-
al control in endothelial cells of tumor vessels of all
lassic KS cases. Besides, all (100%) cases showed positivity
ig. 2. KHE showing dermal proliferation of a mixture of small capillaries and sol
ymphangiomatosis adjacent to the tumor in one of the cases (b), proliferating ce
emosiderin, cytoplasmic vacuolization, areas of hemorrhage and hemosidrin dep
400  (c)].dle tumor cells with slit-like vascular channels in-between, extravasated
ndothelial cells in some areas, sieve-like appearance of small capillaries,
of spindle tumor cells that was diffuse in 6 (60%) cases (2 in
plaque & 4 in nodular stages) and focal in the remaining
4 (40%) cases. But no (0%) case was negative for CD34
(Fig. 5: a-c).
In KHE cases, the tumor vessels of all (100%) cases
showed positivity for CD34 and the tumor cells showed
focal positivity in 2 (25%) cases, diffuse positivity in 4 (50%)
cases, and were negative in the remaining 2 (25%) cases.
Even the areas of associated lymphangiomatosis seen in 4
cases showed CD34 positivity in its lining cells (Fig. 5: d,e).
3.2.3. ˛-SMA expression:
-SMA showed diffuse positivity in the spindle tumor
cells of four (40%) KS cases (1 in plaque & 3 in nodular
stages), focal positivity in 3 (30%) cases, and negative stain-
ing in 3 (30%) cases (2 in plaque & 1 in nodular stages).
While all (100%) KHE cases showed negativity of tumor
cells to -SMA. All studied cases of both tumor groups
showed -SMA positivity in the walls of well formed blood
vessels and in myoﬁbroblastic cells in peritumoral area that
worked as internal positive control (Fig. 6).3.3. Statistical ﬁndings
As regards c-Kit staining, there was no statistical differ-
ence between KS and KHE on comparing the frequency and
id lobules of cells arranged in a glomeruloid pattern (a), a near-by area of
lls are round or ovoid, some contain hyaline globules and others contain
osits are seen but no cellular atypia and no necrosis (c) [H&E X40 (a,b) &
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Fig. 3. Focal positivity of c-Kit in KS (a), positivity was  detected as granular moderate to strong cytoplasmic staining in the spindle tumor cells (b-d) but
no  positivity was  detected in endothelial cells of tumor vessels (black arrows) (d), c-Kit positivity was  also seen in basal keratinocytes (white arrow) (a)
and  entrapped mast cells (e) [Immunoperoxidase X40 (a), X100(b, d), X400 (c, e)].
lls (wh
a), X100Fig. 4. C-Kit expression in KHE showed weak focal positivity in tumor ce
lymphangiomatosis (black arrows) lining cells [Immunoperoxidase X40 (
the pattern of positivity (Table 1) of its expression (p=0.092
for both). However, a statistical signiﬁcance was detected
on comparing the intensity of positive staining in tumors of
both studied groups (Table 2) as stronger c-Kit staining of
scores 2+ & 3+ was signiﬁcantly more frequent in KS than
KHE (p=0.002).
For CD34 expression, there was no signiﬁcant difference
between KS & KHE as regards the frequency of expression
Table 1
Difference between KS and KHE as regards pattern of c-Kit expression:.
Group KS Count 
%  within c-Kit Pattern 
%  of Total 
KHE  Count 
%  within c-Kit Pattern 
%  of Total 
Total  ite arrows) (a, b) & negativity in tumor vessels (red arrows) and near-by
(b), X400 (c)].
(p=0.183), nor on comparing the pattern (Table 3) of its
positivity (p=0.167).
While -SMA showed signiﬁcantly higher frequency of
expression in studied KS cases than KHE cases (p=0.004)
with also signiﬁcant difference in pattern (Table 4) of its
expression (p=0.003).
On correlating c-Kit expression to CD34 expression in all
studied cases and in KHE cases, the correlation didn’t reach
c-Kit Pattern p -value Fisher exact
Negative focal +
4 6 0.092
100.0% 42.9%
22.2% 33.3%
0 8
0.0% 57.1%
0.0% 44.4%
4 14
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ositive (d) [Immunoperoxidase X40 (a), X100(b-d), X400 (e)].
tatistical signiﬁcance (r=0.432, 0.206 & p=0.074, 0.624
espectively). While on correlating between the 2 mark-
rs in KS cases, the correlation was statistically signiﬁcant
r=0.785, p=0.007) which means that high c-Kit expression
oes with high CD34 and vice versa in KS cases (Fig. 7; a).
On correlating c-Kit expression to -SMA expression
n studied cases, there was an inverse statistically signif-
cant relationship (r=-.745, p<0.0001). Also, on correlating
ig. 6. -SMA positivity in the spindle tumor cells of KS (a-c), negativity of tumo
nd  in myoﬁbroblastic cells in peritumoral area (a-e) [Immunoperoxidase X40 (alls of KS (a-c) & KHE (d,e), even the lymphangiomatosis lining cells were
between the 2 markers in KS cases only, there was sta-
tistically signiﬁcant inverse relationship (r=-.874, p=0.001)
which means that higher c-Kit expression was associated
with lower -SMA expression in KS cases (Fig. 7; b&c).
However the correlation was of no signiﬁcance in KHE as
all cases were negative (r=0.435, p=0.282)
On correlating CD34 & -SMA expression in all studied
cases and in KHE group, the correlation was not statistically
r cells in KHE (d, e), positivity in the walls of well formed blood vessels
), X100(b, d), X400 (c, e)].
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Table 2
Difference between KS and KHE as regards intensity of c-Kit positivity:.
c-Kit intensity
1+ 2+ 3+
Group KS Count 1 4 1
%  within c-Kit intensity 11.1% 100.0% 100.0%
%  of Total 7.1% 28.6% 7.1%
KHE Count 8 0 0
%  within c-Kit intensity 88.9% 0.0% 0.0%
%  of Total 57.1% 0.0% 0.0%
Total  9 4 1
Chi-square X2 12.842
p  -value 0.002*
*Signiﬁcant
Table 3
Difference between KS and KHE as regards pattern of CD34 expression:.
CD34 pattern
Negative focal + diffuse +
Group KS Count 0 3 7
%  within CD34 pattern 0.0% 60.0% 63.6%
%  of Total 0.0% 16.7% 38.9%
KHE  Count 2 2 4
%  within CD34 pattern 100.0% 40.0% 36.4%
%  of Total 11.1% 11.1% 22.2%Total  
Chi-square X2
p  -value 
signiﬁcant (r=-0.374, 0.582 & p=0.127, 0.13 respectively).
While in KS group, there was an inverse signiﬁcant cor-
relation (r=-0.88, p=0.001) which means that higher CD34
expression was  associated with lower -SMA expression
in studied cases (Fig. 7; d).
4. Discussion
This study includes 10 classic KS adult cases and 8 KHE
cases. In some countries the classic type of KS dominates
over all other epidemiological types [19]. KHE is a rare vas-
cular neoplasm that occurs in infants and young children
especially in the ﬁrst decade of life [20]. However in the
last few years many cases have also been reported in adults
[21–25]. In the current study, twenty ﬁve percent of KHE
cases were in adult age.
This study shows that both KS and KHE have densely
packed spindled tumor cells with slits and sieve-like
Table 4
Difference between KS and KHE as regards pattern of -SMA expression:.
Group KS Count 
%  within -SMA pattern 
%  of Total 
KHE  Count 
%  within -SMA pattern 
%  of Total 
Total  Count 
Chi-square X2
p  -value 
* Signiﬁcant2 5 11
3.580
0.167
vascular spaces in-between, however, the presence of
nodules of more rounded endothelial cells and ﬁbrin
microthrombi together with the lobular growth pattern
and the lack of chronic inﬂammatory inﬁltrate are more
in favor of KHE and this was  also proven by others [26].
The c-Kit proto-oncogene has tyrosine kinase activity. It
acts as a stem-cell factors’ receptor. Activation of c-Kit in KS
stimulates cell proliferation by increasing the tumor cells
response to growth factors. SCF-dependent proliferation is
reported to be reserved by inhibition of c-Kit activity with
either STI 571, a pharmacological inhibitor of c-Kit, or a
dominant-negative c-Kit protein [27].
Our results show that C-Kit expression, when present,
is detected in cytoplasm of tumor cells of studied cases in
both tumor groups, but is lacking in endothelial cells of
tumor vessels of any of them. It is expressed in 60% of KS
cases and 100% of KHE cases. The difference between KS
& KHE as regards the frequency and the pattern of c-Kit
-SMA pattern
Negative focal + diffuse +
3 3 4
27.3% 100.0% 100.0%
16.7% 16.7% 22.2%
8 0 0
72.7% 0.0% 0.0%
44.4% 0.0% 0.0%
11 3 4
11.840
0.003*
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ositivity in studied cases is not statistically signiﬁcant;
owever, the intensity of positivity was signiﬁcantly higher
n KS (p=0.002). These ﬁndings reveal an essential role for
-Kit in KS and KHE tumorigenesis that can be targeted in
harmacological intervention in these tumors and this is
lso proved by others [27].
Raggo et al. reported that spindle-cell formation in
ermal microvascular endothelial cells is caused by c-Kit
ctivation [28]. To our knowledge no other studies have
ssessed c-Kit expression in KHE, and although a number
f studies in the literature have scrutinized its expression
n KS cases, their results exhibited notable controversies
3,6,9,29,30]. Whereas some authors found no expression
31], others detected the protein in 15.3% [24], 25.6% [26]
r even in 43% of cases [9]. The ﬁgures of our results were
losest to those reported by Pantanowitz et al. (56%) [9]
nd Kandemir et al[3] (62.9%) whose studies were con-
ucted exclusively on classic KS. Kandemir et al. [3] ascribe
his obvious contradiction to the fact the former two  stud-
es [6,31] did not specify the exact epidemiological type
r histological stage under study. Also, they explained the
eviation in results with respect to others was by the vari-
tion in technical parameters, as length of storage and
xation of tissues, the variation in immunohistochemicalt & -SMA in Studied cases (b) & in KS cases (c), and Correlation between
procedures employed [3], in addition to the possibility of
sampling bias [9].
Comparing our results regarding c-Kit positivity in the
different histological stages of KS, to others’, reactivity in
the plaque (66.67%) and nodular (57,14%) phases exceeded
that obtained in the same stages by Pantanowitz et al. (53%,
47% respectively) [9]. It is worth noting, however, that the
later study was  conducted on epidemiologically hetero-
geneous types of KS. In the current study, c-Kit staining
pattern was  focal in all studied cases and this was  compa-
rable to Hussein et al., who reported diffuse in 61.5% and
focal in 38.5% of positive cases of their study [19].
CD34 is a cell surface protein. Its gene is coded on chro-
mosome lq/32. Human myeloid and lymphoid series of
haematopoietic cells as well as endothelial cells express
CD34. CD34 may  have a role in regulation of early events
of blood cell differentiation. Besides, it may  function in
endothelial cells and haematopoietic progenitor cells as an
adhesion molecule [32].
Our results show CD34 expression in both studied
tumor groups. The expression is detected in endothelial
cells of all cases of both tumor groups, in tumor cells of all KS
cases and in tumor cells of 75% of KHE cases with no signif-
icant difference between studied tumor groups as regards
scopy an56 E.A. Hasby et al. / Journal of Micro
the frequency of expression (p=0.183), nor on comparing
the pattern of its positivity (p=0.167).
These results strongly favor a progenitor cell origin of
the tumor cell elements in Kaposi sarcoma and KHE. Sid-
ney et al. reported in 2014 that CD34 is not associated
only with hematopoietic and endothelial cells, but it is
a surface antigen that is suitable for selecting progenitor
cell subpopulations from larger cell populations, including
mesenchymal cells [33]. The presence or absence of CD34
is not an absolute indication of differentiation in a vascular
tumor as it is expressed by blood vessel endothelium and in
lymphatic endothelium in weaker but demonstrable levels
[34].
In this study the well-formed capillaries, the small slit-
like vascular spaces, the sieve-like areas and the spindle
cells have all expressed CD34 in both KHE and KS cases.
This observation is similar to others [22,32,35,36]. In addi-
tion, lymphangiomatoid elements within KHE cases shows
CD34 positivity and this was similar to that is reported by
Ramani, et al. [37].
High c-Kit expression goes with high CD34 and vice
versa in cases of this study (r=0.432 & p=0.074). The correla-
tion between both markers reached statistical signiﬁcance
in KS tumor group (r=0.785, p=0.007), but didn’t reach sta-
tistical signiﬁcance in KHE group (r=0.206 & p= 0.624).
These ﬁndings were similar to Gurzu et al. [18], who
suggested a possible origin of KS from pluripotential mes-
enchymal stem cells of the connective tissue (PMCs) that
were recognized in the connective tissue of dermis, skeletal
muscles, and other organs [38]. These cells can origi-
nate from bone marrow mesenchymal stem cells [39,40],
from reprogrammed ﬁbroblasts [41], or from circulating
ﬁbrocytes [42,43]. They present genetic and epigenetic
abnormalities that can be related to some oncogenic path-
ways. These modiﬁed PMCs secrete cytokines, integrins,
and growth factors and possess a multilineage capacity
[18]. According to the induction medium, these cells can
differentiate into mesodermal or neuroectodermal lineage.
C-KIT and CD34 positivity is obtained in the mesodermal
lineage [44].
-SMA expression was signiﬁcantly of higher frequency
(p=0.004) in KS than KHE with also signiﬁcant difference
in pattern of expression (p=0.003). KHE didn’t show any
positivity in its tumor cells; however both studied groups
showed -SMA positivity in smooth muscle cells of well
formed vessels and in myoﬁbroblastic cells in peritumoral
area.
Higher c-Kit expression was associated with lower -
SMA  expression in studied cases (r=-.745, p<0.0001). This
inverse correlation is highly signiﬁcant in KS group (r=-
.874, p=0.001) and was  of no signiﬁcance in KHE group
(r=0.435, p=0.282) as all cases were negative for -SMA.
Similarly, on correlating CD34 & -SMA expression in all
studied cases and in KHE group, the correlation was  not
statistically signiﬁcant (r=-0.374, 0.582 & p=0.127, 0.13
respectively). While in KS there was an inverse signiﬁcant
correlation (r=-0.88, p=0.001) which means that higher
CD34 expression was associated with lower -SMA expres-
sion in studied cases.
A slight expression of -SMA was also reported in KS
spindled cells [45,46], but its signiﬁcance is not knownd Ultrastructure 5 (2017) 49–57
yet. This ﬁnding was also similar to Gurzu et al. [18]
who  reported that -SMA positivity in KS suggests a
differentiation to myoﬁbroblast-like cells. They added
that this supports a mesenchymal-endothelial rather than
an endothelial-mesenchymal transition. Uldrick et al.
reported that the lower rate of responders to the antiangio-
genic therapy in KS also proves such transition. However,
the cause and signiﬁcance of this phenotypic heterogeneity
are unclear yet [47]. Similar to our ﬁndings in KHE, others
[48,49] reported -SMA expression by pericytes that out-
lines tumor spindle cells, but not by the spindle tumor cells
of KHE.
The aim of this work was  to study the clinicopatho-
logical features of Kaposi sarcoma (KS) & kaposiform
hemangioendothelioma (KHE) and analyze their immuno-
histochemical expression of c-Kit, CD34, -SMA. It is
potentially possible that KS & KHE represent stem cell
tumors that can differentiate into smooth muscle cell–like
phenotype in KS and to endothelial cell like in KHE. Pres-
ence of several dilated lymphatic channels, focal capillary
formation and lack of nuclear atypia and mitosis within
tumor cells, despite a Kaposiform pattern of tumor cells
and the presence of eosinophilic bodies, suggest KHE rather
than KS. C-Kit and CD34 seem to be help in labeling and
diagnosis of KS and KHE, but they do not differentiate
between them. If -SMA also labeled the tumor, then KHE
diagnosis can be ruled out. Much more studies are needed
to clarify the signiﬁcance of expression of such markers,
their correlation to each other and to test the validity of
using agents that inhibit c-Kit activity in such tumors.
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